Education
About Us
Working with TipRanks
Follow Us
CTT Pharmaceutical Holdings Inc (CTTH)
OTHER OTC:CTTH
CTTH Stock Chart & Stats
$0.09
>-$0.01(-0.44%)
At close: 4:00 PM EST
$0.09
>-$0.01(-0.44%)
Day’s Range― - ―
52-Week Range$0.02 - $0.13
Previous CloseN/A
Volume9.07K
Average Volume (3M)66.33K
Market Cap
$5.15M
Enterprise Value$1.86M
Total Cash (Recent Filing)$32.44K
Total Debt (Recent Filing)$17.40K
Price to Earnings (P/E)―
Beta1.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding58,712,230
10 Day Avg. Volume61,896
30 Day Avg. Volume66,327
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)92.48
Price to Sales (P/S)0.00
P/FCF Ratio-87.87
Enterprise Value/Market Cap0.36
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-193.37
Enterprise Value/Ebitda-6.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CTTH FAQ
What was CTT Pharmaceutical Holdings Inc’s price range in the past 12 months?
CTT Pharmaceutical Holdings Inc lowest stock price was $0.02 and its highest was $0.13 in the past 12 months.
What is CTT Pharmaceutical Holdings Inc’s market cap?
CTT Pharmaceutical Holdings Inc’s market cap is $5.15M.
When is CTT Pharmaceutical Holdings Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CTT Pharmaceutical Holdings Inc’s earnings last quarter?
Currently, no data Available
Is CTT Pharmaceutical Holdings Inc overvalued?
According to Wall Street analysts CTT Pharmaceutical Holdings Inc’s price is currently Overvalued.
Does CTT Pharmaceutical Holdings Inc pay dividends?
CTT Pharmaceutical Holdings Inc does not currently pay dividends.
What is CTT Pharmaceutical Holdings Inc’s EPS estimate?
CTT Pharmaceutical Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CTT Pharmaceutical Holdings Inc have?
CTT Pharmaceutical Holdings Inc has 58,712,230 shares outstanding.
What happened to CTT Pharmaceutical Holdings Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CTT Pharmaceutical Holdings Inc?
Currently, no hedge funds are holding shares in CTTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CTT Pharmaceutical Holdings Inc
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---